
Occlutech International AB - Product Pipeline Analysis, 2022 Update
Description
Summary
Occlutech International AB (Occlutech) is a medical device company that develops and supplies heart implant products. The company provides product such as occlutech figulla flex II, sizing occlutech ASD, occlutech PDA occluder, figulla flex UNI, occlutech delivery set, and stiff guidewire. It develops stiff guide wire using a stainless steel core with a PTFE coating. Occlutech’s patented technology platform uses nanotechnologies for coating and covering of implants. The company’s products are used in the treatment of patent ductus arteriosus, arterial septal defects and the left atrial appendage. It operates through research and development, and production facilities located in Germany, Turkey, and Sweden. The company serves across Germany, Italy, France, the UK and Scandinavia. Occlutech is headquartered in Helsingborg, Sweden.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
Occlutech International AB (Occlutech) is a medical device company that develops and supplies heart implant products. The company provides product such as occlutech figulla flex II, sizing occlutech ASD, occlutech PDA occluder, figulla flex UNI, occlutech delivery set, and stiff guidewire. It develops stiff guide wire using a stainless steel core with a PTFE coating. Occlutech’s patented technology platform uses nanotechnologies for coating and covering of implants. The company’s products are used in the treatment of patent ductus arteriosus, arterial septal defects and the left atrial appendage. It operates through research and development, and production facilities located in Germany, Turkey, and Sweden. The company serves across Germany, Italy, France, the UK and Scandinavia. Occlutech is headquartered in Helsingborg, Sweden.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Occlutech International AB
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
36 Pages
- Occlutech International AB Company Overview
- Occlutech International AB Company Snapshot
- Occlutech International AB Pipeline Products and Ongoing Clinical Trials Overview
- Occlutech International AB – Pipeline Analysis Overview
- Occlutech International AB - Key Facts
- Occlutech International AB - Major Products and Services
- Occlutech International AB Pipeline Products by Development Stage
- Occlutech International AB Ongoing Clinical Trials by Trial Status
- Occlutech International AB Pipeline Products Overview
- Dialysis Prosthesis Device
- Dialysis Prosthesis Device Product Overview
- Occlutech Atrial Flow Regulator (AFR) Device
- Occlutech Atrial Flow Regulator (AFR) Device Product Overview
- Occlutech Atrial Flow Regulator (AFR) Device Clinical Trial
- Occlutech Figulla Flex II ASD Occluder
- Occlutech Figulla Flex II ASD Occluder Product Overview
- Occlutech Figulla Flex II ASD Occluder Clinical Trial
- Occlutech Figulla Flex II PFO Occluder
- Occlutech Figulla Flex II PFO Occluder Product Overview
- Occlutech Figulla Flex II PFO Occluder Clinical Trial
- Occlutech Figulla Flex UNI
- Occlutech Figulla Flex UNI Product Overview
- Occlutech Pistol Pusher
- Occlutech Pistol Pusher Product Overview
- Occlutech Pistol Pusher Clinical Trial
- Occlutech International AB - Key Competitors
- Occlutech International AB - Key Employees
- Occlutech International AB - Locations And Subsidiaries
- Head Office
- Recent Developments
- Occlutech International AB, Recent Developments
- Sep 06, 2022: Occlutech Appoints Chief Commercial Officer and Vice President Global Business Development & Marketing
- Aug 24, 2022: Occlutech Q2 2022 - Positive Revenue Growth and Important Milestones Achieved in the Strategic US Market
- Sep 06, 2019: Occlutech AFR heart failure device obtains CE mark approval
- Jan 25, 2018: Occlutech Moves Workforce to Box to Power Cloud Content Management
- Apr 05, 2017: Occlutech Obtains European CE Mark for its Novel PmVSD Occluder
- Jun 02, 2016: Occlutech Obtains European CE Mark Approval For Its LAA Occluder
- Jan 12, 2016: Occlutech Obtains Japanese MHW Approval for its ASD Occlusion Device
- Sep 29, 2015: Occlutech Obtains European CE Approval for Its Novel mVSD Device
- Nov 26, 2014: Occlutech Launches ASD and PFO Occluders in South Korea
- Sep 29, 2014: Occlutech Obtains European CE Approval for its Dedicated Paravalvular Leak Closure Device
- Appendix
- Methodology
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Table 1: Occlutech International AB Pipeline Products and Ongoing Clinical Trials Overview
- Table 2: Occlutech International AB Pipeline Products by Equipment Type
- Figure 1: Occlutech International AB Pipeline Products by Equipment Type
- Table 3: Occlutech International AB Pipeline Products by Indication
- Table 4: Occlutech International AB, Key Facts
- Table 5: Occlutech International AB, Major Products and Services
- Figure 2: Occlutech International AB Pipeline Products by Development Stage
- Table 6: Occlutech International AB Number of Pipeline Products by Development Stage
- Table 7: Occlutech International AB Pipeline Products Summary by Development Stage
- Figure 3: Occlutech International AB Ongoing Clinical Trials by Trial Status
- Table 8: Occlutech International AB Ongoing Clinical Trials by Trial Status
- Table 9: Occlutech International AB Ongoing Clinical Trials Summary
- Table 10: Dialysis Prosthesis Device - Product Status
- Table 11: Dialysis Prosthesis Device - Product Description
- Table 12: Occlutech Atrial Flow Regulator (AFR) Device - Product Status
- Table 13: Occlutech Atrial Flow Regulator (AFR) Device - Product Description
- Table 14: Occlutech Atrial Flow Regulator (AFR) Device - A Multicenter, International, Follow-up Study to Monitor the Efficacy and Safety of the Occlutech Atrial Flow Regulator in Heart Failure Patients
- Table 15: Occlutech Atrial Flow Regulator (AFR) Device - Flow Regulation by Opening the SepTum in Patients with Heart Failure; a Prospective, Randomized, Sham-controlled, Double-blind, Global Multicenter Study
- Table 16: Occlutech Atrial Flow Regulator (AFR) Device - Pomeranian Atrial Flow Regulator in Congestive Heart Failure (PROLONGER) Trial
- Table 17: Occlutech Atrial Flow Regulator (AFR) Device - Prospective, Non-randomized, Pilot Study to Assess Safety and Efficacy of a Novel Atrial Flow Regulator (AFR) in Patients with Pulmonary Hypertension
- Table 18: Occlutech Figulla Flex II ASD Occluder - Product Status
- Table 19: Occlutech Figulla Flex II ASD Occluder - Product Description
- Table 20: Occlutech Figulla Flex II ASD Occluder - Comparative Effectiveness of Three Devices for Transcatheter Closure of Atrial Septal Defects for Adults: A Pilot Study (Trio-ASD)
- Table 21: Occlutech Figulla Flex II ASD Occluder - International Registry for Secundum Atrial Septal Defects Closure by Using the Occlutech Flex II Device in More than 2000 Patients
- Table 22: Occlutech Figulla Flex II ASD Occluder - MitraClip and Hemodynamic Effects of Relevant Iatrogenic Atrial Septum Defect Closure - Evaluation of Morphologic and Functional Changes in a Randomized Setting
- Table 23: Occlutech Figulla Flex II ASD Occluder - Study to Evaluate the Efficacy of Occlutech ASD Occluder in the Treatment of Atrial Septal Defects
- Table 24: Occlutech Figulla Flex II PFO Occluder - Product Status
- Table 25: Occlutech Figulla Flex II PFO Occluder - Product Description
- Table 26: Occlutech Figulla Flex II PFO Occluder - Prospective Randomized Multi-center Controlled Clinical Investigation Comparing Patent Foramen Ovale (PFO) Outcomes of the Occlutech Flex II PFO Occluder to Standard of Care PFO Occlusion
- Table 27: Occlutech Figulla Flex II PFO Occluder - Prospective, Open-label, Multicenter, Non-randomized Investigation on Percutaneous Patent Foramen Ovale (PFO) Closure Using the Occlutech PFO Occluder to Prevent Recurrence of Stroke in Patients with Cryptogenic Stroke and High Risk PFO
- Table 28: Occlutech Figulla Flex UNI - Product Status
- Table 29: Occlutech Figulla Flex UNI - Product Description
- Table 30: Occlutech Pistol Pusher - Product Status
- Table 31: Occlutech Pistol Pusher - Product Description
- Table 32: Occlutech Pistol Pusher - A Registry-based, Multicenter, International, Post Market Follow-up Study to Monitor the Safety, Performance and Usability of Occlutech Accessory Medical Devices:Occlutech Delivery Set (ODS), Occlutech Pistol Pusher (OPP), Occlutech Occlusions-Pusher (OOP), Occlutech Sizing Balloon (OSB) Used During to Implantation Procedures of Cardiac Implant Devices
- Table 33: Occlutech International AB, Key Employees
- Table 34: Glossary
- List of Figures
- Figure 1: Occlutech International AB Pipeline Products by Equipment Type
- Figure 2: Occlutech International AB Pipeline Products by Development Stage
- Figure 3: Occlutech International AB Ongoing Clinical Trials by Trial Status
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.